Case report: Adult presentation of glutaric aciduria type I
Ideggyógyászati szemle · 2026 · 79 (7-8) · 279-283
DOI: 10.18071/isz.79.0279 ↗Kurz gefasst
Fallbericht in der Zeitschrift Ideggyógyászati szemle, 2026. Verfasst von Levente Hadady und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Albert Szent-Györgyi Medical School University of Szeged, Szeged. Hauptthemen laut MEDLINE: Brain Diseases, Metabolic, Glutaryl-CoA Dehydrogenase, Amino Acid Metabolism, Inborn Errors.
Abstract (Originalsprache)
Background and purpose Glutaric aciduria (or glutaric acidemia) type 1 (GA1) is a rare autosomal recessive neurometabolic disorder caused by mutations in the GCDH gene that results in a deficiency of the glutaryl-CoA dehydrogenase enzyme. It plays a vital role in the degradation of L-lysine, L-hydroxylysine, and L-tryptophan. Accumulating toxic metabolites (namely glutaric acid/GA and 3-hydroxyglutaric acid/3-OH-GA) leads to progressive neurological deterioration. GA1 is one of the limited neurometabolic disorders, where we can stop the progression of the disease with a diet and aggressive emergency treatment during excessive catabolism. If undiagnosed through newborn screening, symptoms start to present in childhood between 3-36 months, with neurological symptoms related to sepsis or fever. However, 10-20% of cases start insidiously.
Methods
We report the case of a 53-year-old male with GA1, who presented progressive spastic tetraparesis, dysarthria, and focal seizures. His initial symptoms, misattributed to cerebral palsy and previous ischemic strokes, had gradually worsened in recent years, leaving him bedridden. Specific metabolic laboratory testing and radiological evaluations revealed the characteristic features of the disease. Genetic testing identified a known pathogenic homozygous mutation in the GCDH gene, which confirms the diagnosis of GA1. Low-lysine diet and supplementation with carnitine and riboflavin were started. After the initiation of treatment, no further progression was observable.
Conclusion
This case underscores the importance of considering hereditary neurometabolic disorders like GA1 – taking into account the available metabolic screening – not only in pediatric patients but also in adult patients with progressive neurological decline. This case contributes to the limited literature available on GA1 cases in adults and highlights the need for early detection strategies to avoid irreversible neurological damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Albert Szent-Györgyi Medical School University of Szeged, Szeged.
- Department of Pediatrics and Pediatric Health Center, University of Szeged, Szeged.
- MTA-SZTE Neuroscience Research Group of the Hungarian Academy of Sciences, Szeged.
ORCID-Profile: Levente Hadady, Tibor Kalmár, László Szpisjak, Dénes Zádori, Péter Klivényi, András Salamon
Zitieren
APA
Hadady, L., Dézsi, L., Kalmár, T., Szpisjak, L., Zádori, D., Klivényi, P., & Salamon, A. (2026). Case report: Adult presentation of glutaric aciduria type I. Ideggyógyászati szemle, 79(7-8), 279-283. https://doi.org/10.18071/isz.79.0279
Vancouver
Hadady L, Dézsi L, Kalmár T, Szpisjak L, Zádori D, Klivényi P, et al. Case report: Adult presentation of glutaric aciduria type I. Ideggyógyászati szemle. 2026;79(7-8):279-283. doi:10.18071/isz.79.0279
BibTeX
@article{Hadady2026,
author = {Hadady, Levente and Dézsi, Lívia and Kalmár, Tibor and Szpisjak, László and Zádori, Dénes and Klivényi, Péter and Salamon, András},
title = {Case report: Adult presentation of glutaric aciduria type I},
journal = {Ideggyógyászati szemle},
year = {2026},
volume = {79},
number = {7-8},
pages = {279--283},
doi = {10.18071/isz.79.0279}
}
EUVIMED